Cross Team Document Sharing for CROs
Read Flipbook
eRegulatory
-
-
Florence Mobile App for Sponsors
Read Flipbook
-
Florence Mobile App for CROs
Read Flipbook
-
Demo the Leading eISF, eRegulatory, and eSource Solution
Request A Demo -
Cross Team Document Sharing for Sponsors
Read Flipbook
-
Access a personalized on-demand tour of the Florence eBinders platform
Take The Tour -
What Is Site Enablement?
Site Enablement refers to any technology that prioritizes the needs of clinical research sites. Site Enablement Platforms connect sites, sponsors, and CROs to enable continuous collaboration...
Read Blog
-
Clinical Trial Technology Report Showcases 2023 Trends: Site Enablement, eISFs, and Integrations
Florence Healthcare just released the 2023 State of Clinical Trial Technology Report, with dozens of insights from more than 450 clinical research sites, sponsors, and CROs. We asked these...
Read Blog
-
2023 State of Clinical Trial Site Enablement Technology Report
Read this report to learn the 2023 trends and insights behind the state of technology powering the site and sponsor relationship.
Read Flipbook
-
Investment in Site Enablement to Accelerate Research Grows 300% – Florence Healthcare Releases State of Clinical Trial Technology Report
ATLANTA - January 11, 2023 - Florence Healthcare™, a clinical research technology company, has released its annual State of Clinical Trial Technology Report. Over four hundred clinical research...
Read Blog
-
Clinical Trial Monitoring | In-Person and Remote
Since 2020, clinical research teams have radically changed how they approach clinical trial monitoring–and researchers need to adapt to this change to avoid being left behind. Before the...
Read Blog
-
Why Linking Tech in European Clinical Research Studies is Critical for 2023
Join our expert panel for a discussion to gain insight into the critical trends coming to Europe in 2023.
Watch Video
-
Improving Patient Retention in Clinical Trials
Patient retention in clinical trials is one of the largest challenges facing sites, sponsors, and CROs. The Center for Information and Study on Clinical Research Participation found that 23% of...
Read Blog
-
Florence eBinders Earns Leader Badge in G2’s Fall 2022 Reports
October 12, 2022 - Atlanta, GA - Florence Healthcare™ announced today that eBinders™, their electronic Investigator Site File (eISF) platform used by more than 10,000 research sites, has received...
Read Blog
-
How Technology Can Empower CAR T-Cell Therapy Clinical Trials
CAR T-cell therapy clinical trials are among the most exciting medical advances of the past decade. Since 2017, the FDA has approved 6 CAR T-cell treatments for blood cancers, including lymphomas,...
Read Blog
-
The role of clinical trial technology in creating and managing frontier sites
Historically, clinical trials have been concentrated at academic medical centers, large hospitals, and cancer centers. But under this approach, trials aren’t as inclusive or accessible as they...
Read Blog
-
Linking to the Site's eISF: Why It Matters and How to Do It
Watch Video
-
How Community Sites Can Improve the Lack of Diversity in Clinical Trials
The lack of diversity in clinical trials is one of the most pressing concerns confronting the clinical research industry. The recent FDA guidance for diversity in clinical trials calls on all...
Read Blog
-
How “frontier sites” and hybrid clinical trials can help research sites
The number of clinical trials has increased rapidly since 2020. 2021 saw a 14% increase in trial starts over 2020 and a 19% increase over 2019. And while 2020 was far from a typical year, the...
Read Blog
-
Why eBinders? Resources For Site Leadership
Read Flipbook
-
What is eSource?
Ask 5 clinical trial professionals what eSource is, and you'll get 5 different answers.
Read Blog
-
Florence eBinders Ranked #1 for Clinical Trial Management Software by G2 Users
ATLANTA–(Business Wire)–Florence announced today that eBinders, its clinical research workflow platform, earned the highest ranking in the Clinical Trial Management Systems category of the G2...
Read Blog
-
Loading More...
